Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 2
2003 4
2007 2
2008 2
2009 2
2010 1
2011 2
2012 5
2013 5
2014 2
2015 3
2016 5
2017 1
2018 3
2019 7
2020 5
2021 11
2022 12
2023 8
2024 9
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).
Horak P, Griffith M, Danos AM, Pitel BA, Madhavan S, Liu X, Chow C, Williams H, Carmody L, Barrow-Laing L, Rieke D, Kreutzfeldt S, Stenzinger A, Tamborero D, Benary M, Rajagopal PS, Ida CM, Lesmana H, Satgunaseelan L, Merker JD, Tolstorukov MY, Campregher PV, Warner JL, Rao S, Natesan M, Shen H, Venstrom J, Roy S, Tao K, Kanagal-Shamanna R, Xu X, Ritter DI, Pagel K, Krysiak K, Dubuc A, Akkari YM, Li XS, Lee J, King I, Raca G, Wagner AH, Li MM, Plon SE, Kulkarni S, Griffith OL, Chakravarty D, Sonkin D. Horak P, et al. Among authors: ida cm. Genet Med. 2022 May;24(5):986-998. doi: 10.1016/j.gim.2022.01.001. Epub 2022 Jan 29. Genet Med. 2022. PMID: 35101336 Free PMC article.
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).
Horak P, Griffith M, Danos AM, Pitel BA, Madhavan S, Liu X, Chow C, Williams H, Carmody L, Barrow-Laing L, Rieke D, Kreutzfeldt S, Stenzinger A, Tamborero D, Benary M, Rajagopal PS, Ida CM, Lesmana H, Satgunaseelan L, Merker JD, Tolstorukov MY, Campregher PV, Warner JL, Rao S, Natesan M, Shen H, Venstrom J, Roy S, Tao K, Kanagal-Shamanna R, Xu X, Ritter DI, Pagel K, Krysiak K, Dubuc A, Akkari YM, Li XS, Lee J, King I, Raca G, Wagner AH, Li MM, Plon SE, Kulkarni S, Griffith OL, Chakravarty D, Sonkin D. Horak P, et al. Among authors: ida cm. Genet Med. 2022 Sep;24(9):1991. doi: 10.1016/j.gim.2022.07.001. Genet Med. 2022. PMID: 36063163 Free article. No abstract available.
A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation.
Yanchus C, Drucker KL, Kollmeyer TM, Tsai R, Winick-Ng W, Liang M, Malik A, Pawling J, De Lorenzo SB, Ali A, Decker PA, Kosel ML, Panda A, Al-Zahrani KN, Jiang L, Browning JWL, Lowden C, Geuenich M, Hernandez JJ, Gosio JT, Ahmed M, Loganathan SK, Berman J, Trcka D, Michealraj KA, Fortin J, Carson B, Hollingsworth EW, Jacinto S, Mazrooei P, Zhou L, Elia A, Lupien M, He HH, Murphy DJ, Wang L, Abyzov A, Dennis JW, Maass PG, Campbell K, Wilson MD, Lachance DH, Wrensch M, Wiencke J, Mak T, Pennacchio LA, Dickel DE, Visel A, Wrana J, Taylor MD, Zadeh G, Dirks P, Eckel-Passow JE, Attisano L, Pombo A, Ida CM, Kvon EZ, Jenkins RB, Schramek D. Yanchus C, et al. Among authors: ida cm. Science. 2022 Oct 7;378(6615):68-78. doi: 10.1126/science.abj2890. Epub 2022 Oct 6. Science. 2022. PMID: 36201590 Free PMC article.
Gene Fusions in Ocular Adnexal Tumors.
Milman T, Ida CM, Zhang PJL, Eagle RC Jr. Milman T, et al. Among authors: ida cm. Am J Ophthalmol. 2021 Jan;221:211-225. doi: 10.1016/j.ajo.2020.08.012. Epub 2020 Aug 13. Am J Ophthalmol. 2021. PMID: 32800827 Review.
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas.
Ali MF, Riviere-Cazaux C, Johnson SH, Salvatori R, Penheiter AR, Smadbeck JB, Murphy SJ, Harris FR, McCune LF, Carlstrom LP, Barrett MT, Kosari F, Jones LA, Ida C, Borad MJ, Bendok BR, Quiñones-Hinojosa A, Porter AB, Mrugala MM, Jaeckle KA, Anastasiadis PZ, Kizilbash SH, Cheville JC, Routman DM, Burns TC, Vasmatzis G. Ali MF, et al. Among authors: ida c. Clin Cancer Res. 2025 May 1;31(9):1700-1710. doi: 10.1158/1078-0432.CCR-24-3233. Clin Cancer Res. 2025. PMID: 40019927 Free PMC article.
Characterization of H3K4me3 in mouse oocytes at the metaphase II stage.
Takasu A, Hino T, Takenouchi O, Miyagawa Y, Liang Z, Tanaka S, Mimura T, Ida C, Matsuo Y, Lee Y, Ikegami H, Ohsugi M, Matoba S, Ogura A, Yamagata K, Matsumoto K, Kitajima TS, Miyamoto K. Takasu A, et al. Among authors: ida c. J Biol Chem. 2025 Jul;301(7):110308. doi: 10.1016/j.jbc.2025.110308. Epub 2025 May 29. J Biol Chem. 2025. PMID: 40449591 Free PMC article.
Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer Biomarkers.
Al-Kateb H, Knight SM, Sivasankaran G, Voss JS, Pitel BA, Blommel JH, Jerde CR, Rumilla KM, Lee JL, Mattson NR, Lauer KP, Zimmerman Zuckerman EA, Hofich CD, Milosevic D, Thompson J, Tillmans LS, Stai TT, Dasari S, Pryzbylski AL, Mullineaux LG, Ida CM, Jenkins RB, Gupta S, Kipp BR, Halling KC. Al-Kateb H, et al. Among authors: ida cm. J Mol Diagn. 2025 Apr;27(4):292-305. doi: 10.1016/j.jmoldx.2025.01.002. Epub 2025 Jan 31. J Mol Diagn. 2025. PMID: 39894076 Free article.
98 results